Biocon gets 3 observations from US FDA for Site 3 at Hyderabad

US FDA concluded a pre-approval inspection for Site 3, Biocon Limited, located at Hyderabad, Telangana on 20 July 2022. Three observations were cited at the end of the Inspection, which we will be addressing within the stipulated time. Biocon stands committed to the Quality, Safety & Efficacy of its products.

Shares of Biocon Limited was last trading in BSE at Rs. 331.35 as compared to the previous close of Rs. 326.05. The total number of shares traded during the day was 84829 in over 2171 trades.

The stock hit an intraday high of Rs. 333.80 and intraday low of 324.90. The net turnover during the day was Rs. 28012661.00.

Source : Equity Bulls

Keywords

Biocon INE376G01013 USFDA PreApprovalInspection Site3 Hyderabad 3Observations